Log on / register
Feedback | Support | My details

Comments

Renal safety of zoledronic acid with thalidomide in patients with myeloma: a pharmacokinetic and safety sub-study

Andrew Spencer email, Andrew Roberts email, Nola Kennedy email, Christina Ravera email, Serge Cremers email, Sanela Bilic email, Terry Neeman email, Michael Copeman email, Horst Schran email and Kevin Lynch email

BMC Clinical Pharmacology 2008, 8:2doi:10.1186/1472-6904-8-2

No comments have yet been made on this article

Post a comment

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated